| Literature DB >> 30586597 |
Sami Ullah1, Katja Seidel2, Sibel Türkkan2, Dawid Peter Warwas3, Tatyana Dubich1, Manfred Rohde4, Hansjörg Hauser5, Peter Behrens3, Andreas Kirschning2, Mario Köster1, Dagmar Wirth6.
Abstract
Targeted delivery of drugs is a major challenge in treatment of diverse diseases. Systemically administered drugs demand high doses and are accompanied by poor selectivity and side effects on non-target cells. Here, we introduce a new principle for targeted drug delivery. It is based on macrophages as transporters for nanoparticle-coupled drugs as well as controlled release of drugs by hyperthermia mediated disruption of the cargo cells and simultaneous deliberation of nanoparticle-linked drugs. Hyperthermia is induced by an alternating electromagnetic field (AMF) that induces heat from silica-coated superparamagnetic iron oxide nanoparticles (SPIONs). We show proof-of-principle of controlled release by the simultaneous disruption of the cargo cells and the controlled, AMF induced release of a toxin, which was covalently linked to silica-coated SPIONs via a thermo-sensitive linker. Cells that had not been loaded with SPIONs remain unaffected. Moreover, in a 3D co-culture model we demonstrate specific killing of associated tumour cells when employing a ratio as low as 1:40 (SPION-loaded macrophage: tumour cells). Overall, our results demonstrate that AMF induced drug release from macrophage-entrapped nanoparticles is tightly controlled and may be an attractive novel strategy for targeted drug release.Entities:
Keywords: Cell based drug delivery; Controlled drug delivery, 3D tumour model; Hyperthermia; Macrophages; Magnetic silica nanoparticles
Mesh:
Substances:
Year: 2018 PMID: 30586597 DOI: 10.1016/j.jconrel.2018.12.040
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776